14 Oct
Hadassah’s 44-year-old Sharett Institute of Oncology at Hadassah’s Ein Kerem campus has set the benchmark for preventing, treating and researching cancer in Israel. “Its legacy of cancer care is very strong,” affirmed the Sharett Institute’s new director, Dr. Aron Popovtzer. “We’ve seen a 30 percent increase in patients this past year alone,” said Dr. Popovtzer, […]
READ MORE21 Jan
Edited from an article in The Times, 17 January 2020. Thanks to AI and genome editing, age-defying treatment breakthroughs that were just out of our reach should become reality, says Tom Whipple. In the next ten years medicine will get cleverer, more targeted and personalised. But what is personalised medicine? Experimental genetic therapies find their way […]
READ MORE14 Jan
Dr. Gal Goldstein, Head of Hadassah’s Dyna & Fala Weinstock Department of Paediatric Haemato-Oncology. (photo credit: MARC ISRAEL SELLEM) Hadassah invested a lot of energy, time and money to re-establish the department. BY RIVKAH LAMBERT ADLER Jerusalem Post JANUARY 5, 2019 You wouldn’t think a paediatric oncology department would be a laughter-filled place, but Nurse […]
READ MOREHadassah UK © 2022 | w/creators with Web Studio Lab
Join our digital newsletter to stay in touch with the latest news from Hadassah UK